Dr. Juan Martin Gimenez, MD

Dr. Gimenez practices at Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System.

Dr. Gimenez's NPI, 1306006325, was assigned on June 12, 2008. Dr. Gimenez graduated from Louisiana State University School of Medicine in New Orleans in 2008. Dr. Gimenez holds Florida license ME120047.

Dr. Gimenez's primary practice is Ochsner Medical Center - New Orleans, at 1516 Jefferson Hwy, New Orleans, LA 70121 in Jefferson Parish. The practice phone is (504) 842-3000.

Dr. Gimenez's primary practice is Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System. Dr. Gimenez is also affiliated with CHRISTUS Ochsner St. Patrick Hospital. The medical group on file is Ochsner Health. Dmand AI also links Dr. Gimenez to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gimenez practices, 2 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Gimenez's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Gimenez is licensed in Florida.

CMS data shows 695 Medicare services from Dr. Gimenez across 17 procedure codes in 2024, for 198 Medicare patients. Medicare paid $38,479 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 198 Medicare patients who saw Dr. Gimenez in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gimenez's median patient age at 71, with 49% women.

In 2024, Dr. Gimenez wrote 31 Medicare Part D claims for 12 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $43 in total drug cost.

Dr. Gimenez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Gimenez, published from 2017 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Carcinoma, Hepatocellular, Liver Neoplasms and Venous Thrombosis. Dr. Gimenez has published most often in J Vasc Interv Radiol. Dr. Gimenez's most frequent co-authors are Tyler A. Sandow, Patrick Gilbert, MD and Muneeb Ahmed, MD.

Dmand AI links Dr. Gimenez to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Neuroendocrine Tumors and Neuroectodermal Tumors.

CMS Open Payments shows 876 general payments to Dr. Gimenez from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Boston Scientific Corporation paid the most, $526,689.

Dr. Gimenez graduated from Louisiana State University School of Medicine in New Orleans in 2008.